Organon & Co - Company Profile
Powered by 
All the sales intelligence you need on Organon & Co in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Organon & Co fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Organon & Co.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Organon & Co’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Organon & Co's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Carrie S. Cox
Chairman Executive BoardMs. Carrie S. Cox has been the Chairman of the company since 2021. Prior to this, she served as the Chairman and Chief Executive Officer at Humacyte Inc; Executive Vice President of Schering-Plough and President of Schering-Plough’s Global Pharmaceutical Business. Ms. Cox also served as the President of Pharmacia Corporation’s Pharmaceutical Business. Currently, she serves on the Board of Directors of Texas Instruments Inc since 2004, Cardinal Health Inc since 2009, and Selecta Biosciences Inc since 2019.
Matthew Walsh
Executive Vice President; Chief Financial Officer Senior ManagementMr. Matthew Walsh has been the Chief Financial Officer and Executive Vice President of the company since 2021. Prior to this, he served as the Executive Vice President and Chief Financial Officer at Allergan and Catalent. Mr. Matthew served in several finance and leadership positions at Escala Group and GenTek.
Daniel Karp
Chief Strategy Officer; Head - Corporate Development Senior ManagementMr. Daniel Karp has been Head of Corporate Development and Chief Strategy Officer of the company since 2024. Earlier, he served as the Executive Vice President, Corporate Development at Biogen. Previously, he held a number of positions of increasing responsibility at Pfizer, including Vice President, Head of Business Development for Worldwide Research & Development, and Vice President, Head of Business Development for Pfizer Vaccines, Oncology and Consumer Healthcare.
Juan Camilo Arjona Ferreira
Head - Research & Development; Chief Medical Officer; Executive Vice President Senior ManagementMr. Juan Camilo Arjona Ferreira has been the Chief Medical Officer, Executive Vice President and Head of Research and Development of the company since 2024. Prior to this, he served as the Chief Medical Officer of Myovant Sciences Inc and Senior Vice President of Clinical Development at Shionogi Inc.
Rachel Stahler
Chief Digital and Growth Officer; Executive Vice President Senior ManagementMs. Rachel Stahler has been the Chief Commercial Innovation Officer, Chief Digital Officer, and Executive Vice President of the company since February 2025. Prior to this, she served as the Chief Information Officer of the company. Previously, she served as the Chief Information Officer of Allergan. Ms. Stahler also served as the Chief Information Officer of Syneos Health, inVentiv Health and Optimer Pharmaceuticals and served in senior technology roles at Pfizer.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer